At the moment CAD is managed using off-label therapies, including rituximab and corticosteroid drugs, and sutimlimab's potential to improve treatment earned it a breakthrough designation from the FDA.

For those with CAD, medication may be necessary to control cholesterol, regulate blood pressure, or prevent blood clots. Taking medications as prescribed by a healthcare provider helps lower the ...